Skip to main content

Medicare plans to pay for controversial Alzheimer's drug, if patients enroll in trials

By NBC News  
   January 11, 2022

Medicare plans to provide insurance coverage for Aduhelm, a contentious Alzheimer's treatment from the drugmaker Biogen, CMS announced Tuesday.

Full story


Get the latest on healthcare leadership in your inbox.